Supply chain mapping: A best practice for the biopharma industry

The complexity of the support networks needed to deliver biopharma products, makes good supply chain mapping (SCM) essential to ensure reliable drug product supply.  This is especially the case given the impact that natural disasters, adverse weather and politics can have on supply chain security. Good SCM enhances biopharmaceutical companies' ability to plan and react to situations thanks to greater transparency and visibility through the supply chain.

To help, the Supply Chain Mapping workstream has developed a best practice guide that can be tailored to the needs of both suppliers and manufacturers and helps them map and master supply chain risk.  The guide details five reasons why a company should adopt this approach: patient safety, regulations, supply security, financial benefits and reputation. The guide includes an implementation model, a standardized questionnaire that can be utilized to collate and manage basic supplier data and a maturity model against which a company can assess its own level of supply chain mapping and understanding. There is also an outline of the performance management metrics and characteristics that can be used by a company to develop a SCM solution to meet its own needs.

Attached Files

  • Version
  • Download 332
  • File Size 0.00 KB
  • File Count 1
  • Create Date 25th May 2018
  • DOI
  • Last Updated